EDGAR Filing Documents for 0001493152-18-008102

Form 8-K - Current report:

SEC Accession No. 0001493152-18-008102

Filing Date

2018-06-01

Accepted

2018-06-01 07:00:39

Documents

Period of Report

2018-06-01

Items

Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1		form8-k.htm	8-K	24974
2		ex99-1.htm	EX-99.1	26301
3		ex99-1_001.jpg	GRAPHIC	44406
4		ex99-1_002.jpg	GRAPHIC	699617
5		ex99-1_003.jpg	GRAPHIC	330908
6		ex99-1_004.jpg	GRAPHIC	249218
7		ex99-1_005.jpg	GRAPHIC	339438
8		ex99-1_006.jpg	GRAPHIC	268230
9		ex99-1_007.jpg	GRAPHIC	300466
10		ex99-1_008.jpg	GRAPHIC	426818
11		ex99-1_009.jpg	GRAPHIC	486901
12		ex99-1_010.jpg	GRAPHIC	392989
13		ex99-1_011.jpg	GRAPHIC	124968
14		ex99-1_012.jpg	GRAPHIC	295665
15		ex99-1_013.jpg	GRAPHIC	124383
16		ex99-1_014.jpg	GRAPHIC	537346
17		ex99-1_015.jpg	GRAPHIC	568125
18		ex99-1_016.jpg	GRAPHIC	442516
19		ex99-1_017.jpg	GRAPHIC	41235
20		ex99-1_018.jpg	GRAPHIC	540975
21		ex99-1_019.jpg	GRAPHIC	316233
22		ex99-1_020.jpg	GRAPHIC	70846
23		ex99-1_021.jpg	GRAPHIC	784548
24		ex99-1_022.jpg	GRAPHIC	436358
25		ex99-1_023.jpg	GRAPHIC	766348
26		ex99-1_024.jpg	GRAPHIC	966927
	Complete submission text file	0001493152-18-008102.txt		13215782

Mailing Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130

Business Address 12264 EL CAMINO REAL SUITE 350 SAN DIEGO CA 92130 858-704-4042

Imprimis Pharmaceuticals, Inc. (Filer) CIK: 0001360214 (see all company filings)